Takahiro Iizuka-Takiyama

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

A case of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis presenting with characteristic symptoms such as altered sense of time, visual distortion and hallucinations

A case of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis presenting with characteristic symptoms such as altered sense of time, visual distortion and hallucinations

Journal: Rinsho shinkeigaku = Clinical neurology

Published: August 10, 2026

Longitudinal changes in brain volume, cognitive function, and seizure outcomes in cryptogenic new-onset refractory status epilepticus.

Longitudinal changes in brain volume, cognitive function, and seizure outcomes in cryptogenic new-onset refractory status epilepticus.

Journal: Journal of the neurological sciences

Published: February 10, 2026

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Journal: Annals of neurology

Published: December 18, 2025

Early Recovery from Cryptogenic NORSE Following Repeated C-NORSE Score Assessment and Cyclophosphamide Treatment.

Early Recovery from Cryptogenic NORSE Following Repeated C-NORSE Score Assessment and Cyclophosphamide Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: October 22, 2025

Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis: Markers of Severity and Outcome.

Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis: Markers of Severity and Outcome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 20, 2025

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study.

Journal: The Lancet. Neurology

Published: October 17, 2025

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.

Journal: Annals of neurology

Published: October 06, 2025

Utility of the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) Score to Define Relapse in the Scarcity of Biomarker Footprints in Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis: A Case Report.

Utility of the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) Score to Define Relapse in the Scarcity of Biomarker Footprints in Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis: A Case Report.

Journal: Cureus

Published: September 26, 2025

Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies: Clinical Features and Outcomes.

Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies: Clinical Features and Outcomes.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 15, 2025

Genome-shock deletion of a hybrid lethality gene breaks a reproductive barrier and facilitates speciation in Nicotiana.

Genome-shock deletion of a hybrid lethality gene breaks a reproductive barrier and facilitates speciation in Nicotiana.

Journal: Frontiers in plant science

Published: August 22, 2025

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Journal: The Lancet regional health. Europe

Published: July 24, 2025

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026